Lilly, partner lose court fight over testosterone treatment
Eli Lilly and Co. and its partner cannot stop competitors from selling generic versions of testosterone treatment Axiron, a federal judge in Indianapolis has ruled.
Health Care Businesses
Articles
St. Vincent plans to build ‘micro-hospitals’ throughout area
St. Vincent will expand its footprint in central Indiana by opening eight small hospitals where patients can get treated for medical conditions that aren’t life-threatening. The first four locations were announced Monday.
Lilly drug for Alzheimer’s gets fast-tracked by FDA
Named AZD3293, the drug belongs to a novel class of drugs that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
Carmel doctor found not guilty of charges from 2014 raid
Judge Steve Nation found that Dr. Larry Ley had met all of the standards for prescribing medicine for drug addiction after a bench trial in Hamilton County Superior Court.
Cialis users sue Lilly, claiming drug has ties to skin cancer
Seven men who took Cialis pills to treat erectile dysfunction sued Indianapolis drugmaker Eli Lilly and Co. this week, claiming they later suffered from skin cancer that was related to the medicine.
AIT meltdown derails huge Marian gift
Five years after pledging an astounding $48 million to help Marian University build a medical school, an Indianapolis businessman has paid only about one-fifth of that amount.
Incoming Lilly CEO pick to focus globally
Dave Ricks will begin guiding the company during a period of relative calm compared with the trying times John Lechleiter navigated during his eight years at the helm.
‘Smooth transition’ predicted as Lilly turns to experienced exec
Over the last eight years, Eli Lilly relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline. Now, it’ll rely on another long-time executive for its next chapter.
Lilly beats analyst expectations, lays out bright outlook for rest of decade
CEO John Lechleiter said the company's strong R&D pipeline has put it on track to report average annual revenue growth of at least 5 percent through the remainder of the decade.
Lilly stock rises after FDA panel backs new Jardiance label
A hot-selling drug for diabetes sold by Eli Lilly and Co. and a co-partner just got another potential boost, as a government panel narrowly recommended that the companies should be allowed to claim that the drug cuts the risk of cardiovascular death.
Study: Docs who get free meals pick branded drugs more
Doctors who accept free meals from the pharmaceutical industry are more likely to prescribe certain branded drugs to Medicare patients than generics, according to a study published Monday.
Indiana gains ground in Fortune 500 amid shuffle among elite
Indianapolis-based Simon Property Group Inc. and Warsaw’s Zimmer Biomet Holdings vaulted back among the top 500 this year, while local oil refiner Calumet Specialty Products Partners plummeted.
Troubled home health care provider Nightingale to sell itself
One of Indiana’s largest home health care providers, facing allegations that it put patients in immediate jeopardy, has agreed to be acquired by a competing company in a deal that could be worth as much as $3 million.
Merck, Pfizer double size of diabetes drug study to catch rivals
The competition heated up in the $71.5 billion global diabetes market last year after Indianapolis-based Eli Lilly’s and Boehringer Ingelheim’s Jardiance unexpectedly reduced the risk of heart attacks, strokes and deaths in a study.
CEO Lechleiter says Lilly in ‘most prolific period of new launches’
The Indianapolis-based drugmaker said Tuesday it has built a robust pipeline of drugs that “has the potential” to launch 20 new products in the 10 years between 2014 and 2023.
AIT Labs founder to return more than $3M in settlement
The founder of AIT Laboratories, along with his insurance companies and bank, will pay back more than $3 million to employees who bought the company from him six years ago at what the government said was an inflated price.
Judge awards ex-Lilly manager $500,000 after lawsuit
A federal judge made the award to Lilly’s former executive director of human resources, who quit for health reasons and was later dropped from the company’s extended disability plan.
Toxicology labs face tough times
Deep cuts in Medicare reimbursements and competition from a few huge national chains and walk-in labs are making it tougher for Indianapolis-based AIT and other toxicology labs to compete.
Cook recalling 4.1 million catheters after reports of splitting or breaking
It’s the largest recall in recent years for Cook, which previously had issued four recalls covering more than 400,000 catheters and pressuring monitoring sets in the past two years.
Sale of local medical-device maker could bring $200 million
PTS Diagnostics, with about 150 employees in Indianapolis, said Monday it has entered a definitive agreement to be acquired by China-based Sinocare Inc.